Thin pen needle size
Terumo-thin wall technology
Nanopass® 32.5G Pen Needles are intended for use with a pen injector for subcutaneous applications of drugs (ex. insulin and human growth hormone).
Nanopass®32.5G is not sold in North America.
Does not contain components made of natural rubber latex.
1 Patented technology
2 Pen needle design influences ease of insertion, pain and skin trauma in subjects with type 2 diabetes Kezia A Praestmark, 1, E, Morten L Jenzen, 3 Nils B Madsen, 2 JOnas Kildegaard, 4 Bente M Stallknecht 1
3 Data on file
Innovation and creativity are central to Terumo Pharmaceutical Solutions’ value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.
Didn't find your product?
This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals).
This is HCP only content